便秘之前的抑郁症:一个基于人口的队列研究
Qingping Yun1, Shiyu Wang1, Shanquan Chen2
1Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
EClinicalMedicine
|January 24, 2024
概括
便秘可能会增加患抑郁症的风险. 这项研究发现,便秘患者的风险增加了48%,这表明潜在的联系超出了简单的症状.
科学领域:
- 胃肠病学和精神病学 在
- 肠-大脑轴研究研究
- 流行病学 流行病学
背景情况:
- 便秘通常被视为抑郁症的症状或副作用.
- 肠-大脑轴假设表明肠道健康和心理健康之间存在双向关系.
- 这项研究探讨了便秘作为抑郁症的前兆的潜力.
研究的目的:
- 为了研究先发性便秘和随后的抑郁症发展之间的关联.
- 为了确定便秘是否是一个独立的危险因素或抑郁症的早期迹象.
- 为医疗保健专业人员提供关于心理健康中肠-大脑连接的证据.
主要方法:
- 一项回顾性队列研究,利用2006-2010年英国生物库数据.
- 纳入标准:在基线没有抑郁症的个人.
- 通过诊断码和问卷评估便秘;使用多个数据源追踪到2022年的抑郁症发病率.
主要成果:
- 分析了超过449,000名参与者,其中4.1%的人经历了便秘,4.1%的人患有抑郁症.
- 病前便秘与2.28倍的抑郁症风险增加有关.
- 调整后的分析显示,便秘患者患抑郁症的风险增加了48% (aHR为1.48),抑郁症状的发现也相似 (aOR为2.18).
结论:
- 被诊断和自我报告的便秘都可能与抑郁症风险增加有关.
- 便秘可能作为一个独立的危险因素或抑郁症的前兆症状.
- 临床医生,特别是胃肠科医生和初级保健医生,应考虑便秘患者的心理健康问题.
相关概念视频
Depressive Disorders: Etiology
102
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
102
Depression: Overview
244
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
244
Drugs for Treatment of Constipation-Predominant IBS
169
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
169
Depressive Disorders: MDD and Dysthymia
136
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
136
Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
161
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
161


